In endemic regions:

• achieve and sustain certification standard surveillance for acute flaccid paralysis (AFP) at the national level
• identify and close any gaps in surveillance performance at the sub-national level in all countries
• increase the speed of surveillance and virological data analysis to ensure timely emergency response.

In certified polio-free regions:

• maintain certification-standard surveillance for acute flaccid paralysis
• ensure highest possible immunity levels against wild poliovirus
• develop action plans for responding rapidly to importations of wild poliovirus
• integrate AFP reporting into national surveillance mechanisms to respond to other important diseases.

• reduce the time required for intratypic differentiation (ITD) results to be available from endemic areas
• ITD capacity established in all polio reservoir countries
• sustain the international capacity to process all specimens from AFP cases in WHO-accredited laboratories through global certification and oral polio vaccine (OPV) cessation.

• further dissemination and national implementation of activities outlined in the Global action plan for laboratory containment of wild polioviruses 2003
• complete laboratory survey and inventory activities in all polio-free countries
• prepare for implementation of phase II laboratory containment activities prior to global certification
• initiate phase II containment activities in all countries
• complete biosafety level-3 (BSL-3)/polio containment in facilities producing IPV from wild poliovirus.

• regional certification commissions (RCC) in the remaining three polio-endemic regions to train national certification commissions (NCC)
• NCCs to collect, review and decide on the national documentation through consultations
• The GCC to finalize:

1. the data requirements for global certification from the three certified polio-free regions
2. the role of environmental surveillance as a supplemental strategy
3. mechanisms for reviewing and verifying documentation on the containment of laboratory stocks and IPV production.